Life Science

A chromogenic substrate for many PLA2s including sPLA2, cPLA2, and iPLA2.

A chromogenic substrate for many PLA2s including sPLA2, cPLA2, and iPLA2.

A thioester substrate analog of 2-AG that can be utilized for the measurement of MAGL activity hydrolysis of the thioester bond by MAGL generates a free thiol that reacts rapidly with the chromogenic reagent DTNB resulting in a yellow product with

A thioester substrate analog of 2-AG that can be utilized for the measurement of MAGL activity hydrolysis of the thioester bond by MAGL generates a free thiol that reacts rapidly with the chromogenic reagent DTNB resulting in a yellow product with

A thioester substrate analog of 2-AG that can be utilized for the measurement of MAGL activity hydrolysis of the thioester bond by MAGL generates a free thiol that reacts rapidly with the chromogenic reagent DTNB resulting in a yellow product with

A thioester substrate analog of 2-AG that can be utilized for the measurement of MAGL activity hydrolysis of the thioester bond by MAGL generates a free thiol that reacts rapidly with the chromogenic reagent DTNB resulting in a yellow product with

An analog of AEA in which the alcohol of the ethanolamide group has been replaced with a fluorine atom, which increases the binding affinity and selectivity for the CB1 receptor in vivo activity is enhanced much less than the binding affinity,

An analog of AEA in which the alcohol of the ethanolamide group has been replaced with a fluorine atom, which increases the binding affinity and selectivity for the CB1 receptor in vivo activity is enhanced much less than the binding affinity,

An analog of AEA in which the alcohol of the ethanolamide group has been replaced with a fluorine atom, which increases the binding affinity and selectivity for the CB1 receptor in vivo activity is enhanced much less than the binding affinity,

An analog of AEA in which the alcohol of the ethanolamide group has been replaced with a fluorine atom, which increases the binding affinity and selectivity for the CB1 receptor in vivo activity is enhanced much less than the binding affinity,

An analog of AEA that exhibits weak or no binding to the human CB1 receptor (Ki &gt1 &microM) inhibits rat glial gap junction cell-cell communication at a concentration of 50 &microM.

An analog of AEA that exhibits weak or no binding to the human CB1 receptor (Ki &gt1 &microM) inhibits rat glial gap junction cell-cell communication at a concentration of 50 &microM.